Stool studies are ordered because the stool carries direct evidence of what is happening in a part of the body you cannot see or palpate. They answer four broad questions: is there infection, is there inflammation, is there bleeding, and is the gut absorbing nutrients. Cultures and molecular panels identify pathogens in acute or bloody diarrhea; calprotectin, lactoferrin, and leukocyte smears reveal mucosal inflammation and help separate inflammatory bowel disease from irritable bowel syndrome; occult blood testing and the Apt test address bleeding and its source; and quantitative fecal fat measures absorption. Because these tests are noninvasive and inexpensive, they are often used to decide who genuinely needs endoscopy and who does not. They also serve public health, since several enteric pathogens are reportable and identifying them triggers contact tracing and outbreak control. As the nurse, your history taking often narrows the study before the specimen is even collected, because recent travel, antibiotic exposure, food sources, symptom duration, and stool description determine which test will actually answer the question.
The accuracy of every stool study depends on collection technique, and that is nursing work. Teach the patient to void before collecting so urine does not enter the specimen, to use a collection hat, clean bedpan, or plastic wrap over the toilet rather than collecting from the bowl water, and to keep toilet paper out of the container because it contains chemicals that interfere with several assays. Confirm any required preparation before collection begins: a measured high-fat diet for fecal fat, holding NSAIDs for inflammatory markers, and collecting culture specimens before antibiotics are started. Barium, mineral oil, oily laxatives, enemas, bismuth preparations, and antidiarrheal agents interfere with many stool tests, so stool studies should be scheduled before contrast examinations, not after. Label the container at the bedside with the patient's identifiers and the exact date and time of collection, and note whether the specimen was formed, loose, bloody, or mucoid. Use gloves and standard precautions for every specimen, transport promptly, and refrigerate or use transport medium according to the specific test and your laboratory's policy, because delay is the single most common reason a stool study has to be repeated.
Stool results come back in several different formats, and knowing which one you are reading prevents misinterpretation. Culture and molecular panels report qualitatively as organisms isolated or not detected, with a susceptibility panel attached when a bacterial isolate is recovered. Screening smears such as fecal leukocytes are reported descriptively as present or absent, sometimes with a rough estimate of quantity. Inflammatory markers such as calprotectin and lactoferrin are reported numerically against a laboratory-specific cutoff, so the same patient value can be labeled normal by one laboratory and borderline by another; always compare the number to the range printed on that report. Quantitative fecal fat is reported as grams of fat per 24 hours and is meaningless unless the collection duration and the fat content of the diet are documented alongside it. Critical or reportable findings, including certain enteric pathogens and toxin results, require prompt notification of the provider and often of infection prevention or public health. Document the result, the time you were notified, who you notified, and what was ordered in response.
No fetal hemoglobin detected. The blood in the specimen is maternal in origin, meaning the newborn swallowed the mother's blood rather than bleeding internally.
It is ordered when a newborn passes bloody stool or vomits blood in the first days of life. The clinical question is urgent and narrow: is the baby bleeding, or did the baby swallow the mother's blood during delivery or during breastfeeding from a cracked, bleeding nipple? The answer changes the plan completely, from reassurance and lactation support to a workup for necrotizing enterocolitis or a bleeding disorder.
Fetal hemoglobin resists breakdown by a strong alkali, while adult hemoglobin does not. The laboratory mixes the bloody specimen with a sodium hydroxide solution and watches the color. If the mixture stays pink, the blood is the baby's; if it turns yellow-brown, the hemoglobin has denatured and the blood came from the mother.
The specimen must contain visibly red, reasonably fresh blood. Old, dark, tarry, or dried blood has already degraded and gives an unreliable or falsely maternal result. Very small amounts of blood, stool heavily diluted with formula or mucus, and long delays before the specimen reaches the laboratory all reduce accuracy.
No preparation of the infant is required and there is no fasting. Save the actual bloody diaper, emesis, or gastric aspirate rather than describing it. Label the specimen with the infant's identifiers, the time it was passed, and whether it is stool or emesis. Take a quick feeding history at the same time and inspect the mother's nipples for cracking or bleeding, because that history often explains the result before the laboratory does.
There is nothing done to the infant. Your role is specimen handling: get the sample to the laboratory promptly so the blood does not degrade, and keep the parents informed. Parents who have just seen blood in a diaper are frightened, so explain plainly that this test tells the team whose blood it is.
Continue to monitor the infant for further bleeding, abdominal distention, feeding intolerance, temperature instability, and changes in activity while results are pending. Document the amount and appearance of any further bloody stools or emesis. If the blood proved to be maternal, support the mother with feeding technique and nipple care.
A result showing fetal hemoglobin confirms the newborn is truly bleeding. Causes include necrotizing enterocolitis, hemorrhagic disease of the newborn from vitamin K deficiency, anal fissure, stress ulcer, malrotation with volvulus, milk protein allergy, or a coagulation disorder. A maternal result points instead to swallowed blood from delivery or from a bleeding nipple and generally needs no gastrointestinal workup.
Send visibly bloody, freshly passed specimen immediately, and never assume bleeding is benign until the source is proven maternal.
Negative or low. Most laboratories report a normal adult value as roughly under 50 micrograms per gram of stool, with a borderline zone above that and clearly elevated values well above it. Cutoffs vary by assay, so always read the value against the reporting laboratory's own reference range rather than a memorized number.
It separates inflammatory bowel disease from irritable bowel syndrome in a patient with chronic diarrhea or abdominal pain, which spares many patients an unnecessary colonoscopy. In a patient already diagnosed with Crohn disease or ulcerative colitis, it is used to track disease activity, detect a relapse before symptoms escalate, and judge whether mucosal healing is occurring on therapy.
Calprotectin is a protein carried in the cytoplasm of neutrophils. When the intestinal lining is inflamed, neutrophils migrate into the bowel wall and lumen and shed this protein into the stool, where it is stable for days. The laboratory measures its concentration by immunoassay, so the number rises and falls roughly in proportion to how much neutrophil traffic is crossing the mucosa.
Nonsteroidal anti-inflammatory drugs and aspirin cause mucosal injury and raise the value, so patients are usually asked to hold them for several days if the provider agrees. Proton pump inhibitors can also raise it. The test reports inflammation, not its cause, so gastrointestinal infection, diverticulitis, polyps, colorectal cancer, and recent gastrointestinal bleeding all elevate it. Infants and young children run higher baseline values. Urine or water contamination dilutes the specimen, and a sample left at room temperature too long before processing gives a falsely low result.
Explain that only a single random stool sample is needed and that there is no diet preparation or fasting. Review the medication list with the provider for NSAIDs and proton pump inhibitors. Give the patient the collection container and a collection device or clean hat that fits the toilet, and teach them not to let the sample touch toilet water and not to collect from a toilet bowl.
The patient collects the specimen. Instruct them to take a small, walnut-sized portion of formed stool or a few milliliters of liquid stool, place it in the container without adding preservative unless the kit supplies one, close it securely, and keep it refrigerated until it is delivered. Wear gloves and use standard precautions for any specimen you handle.
No physical recovery is needed. Refrigerate the specimen and transport it to the laboratory within the interval the laboratory specifies. Resume any held medications once the sample is submitted, and reinforce that a single number is interpreted alongside symptoms, not alone.
An elevated result indicates active inflammation of the intestinal mucosa and supports inflammatory bowel disease, infectious colitis, NSAID enteropathy, diverticulitis, or neoplasm. A rising value in a known IBD patient often signals relapse before symptoms worsen. A low value makes intestinal inflammation unlikely and points toward a functional disorder such as irritable bowel syndrome.
Treat this as a marker of inflammation, not a diagnosis, and refrigerate the specimen promptly, because delay falsely lowers the result.
Adults excrete less than about 7 grams of fat per 24 hours while eating a diet containing roughly 100 grams of fat daily, which corresponds to absorbing more than 95 percent of ingested fat. Infants absorb less efficiently, so a somewhat higher percentage of fat loss is normal for them. A qualitative Sudan stain screen is reported simply as negative, meaning no increase in fat globules.
It is the reference test for steatorrhea, the excretion of excess fat in stool. It is ordered when a patient reports bulky, greasy, foul-smelling, floating stools, unexplained weight loss, or fat-soluble vitamin deficiency, and it is used to confirm and quantify malabsorption and to follow the response to pancreatic enzyme replacement.
Fat that is not digested by pancreatic lipase or not solubilized by bile salts, and fat that the small intestinal mucosa cannot absorb, passes into the stool. All stool passed over a timed period is collected, weighed, homogenized, and chemically extracted so the total fat can be measured and divided by the number of days. A qualitative smear stained with Sudan dye is a faster but far less precise screen.
Mineral oil, castor oil, other oily laxatives, and rectal suppositories or creams add fat that never came from food. Barium from a recent contrast study, enemas, and bulk laxatives such as psyllium alter stool composition and volume. Toilet paper and urine in the container invalidate the specimen. The largest single source of error is an inadequate fat intake during the collection, which can make a truly malabsorbing patient look normal, and any missed stool during the timed window, which falsely lowers the total.
The patient eats a measured high-fat diet of about 100 grams of fat per day for two to three days before collection and throughout the collection period, and continues it until the last specimen is passed. Hold mineral oil, laxatives, enemas, and rectal preparations for several days beforehand with provider agreement, and schedule the study before, not after, any barium contrast examination. Teach the collection method carefully, because this test depends almost entirely on the patient doing it correctly.
The standard quantitative collection runs 72 hours, and every stool passed during that period goes into the collection container, with the start and stop times written down. Give the patient a large preweighed container and a toilet hat, and instruct them to keep the container refrigerated or on ice, to void first so urine does not enter the specimen, and to discard toilet paper separately. Your role is to check daily that the diet is being followed, that no stool has been flushed, and that the container is being kept cold.
Send the entire collection to the laboratory with the exact collection times documented. Return the patient to their usual diet and restart held medications. Reinforce that a single missed stool or a low-fat meal during the window can force the test to be repeated.
An elevated fecal fat confirms malabsorption but does not name its cause. Pancreatic causes include chronic pancreatitis, cystic fibrosis, pancreatic carcinoma, and pancreatic duct obstruction. Intestinal mucosal causes include celiac disease, Crohn disease, Whipple disease, giardiasis, radiation enteritis, and short bowel syndrome after resection. Reduced bile delivery from biliary obstruction or severe liver disease also produces steatorrhea, as does bacterial overgrowth.
The result is only as good as the collection, so verify the full 100-gram fat diet and that every stool over the entire 72 hours reached the refrigerated container.
Negative, meaning no significant lactoferrin is detected in the stool. Quantitative assays report a low value against the performing laboratory's cutoff.
It is used to tell inflammatory diarrhea from noninflammatory diarrhea, which narrows the differential quickly in a patient with persistent loose stools. Like calprotectin, it helps separate inflammatory bowel disease from irritable bowel syndrome, tracks disease activity in known Crohn disease and ulcerative colitis, and can support a diagnosis of pouchitis after ileoanal pouch surgery.
Lactoferrin is an iron-binding glycoprotein stored in the granules of neutrophils. When neutrophils enter the intestinal lumen because the mucosa is inflamed, they release and shed lactoferrin into the stool. Because the protein survives intestinal transit better than an intact white cell does, the immunoassay detects inflammation even in a specimen too old for a useful leukocyte smear.
Human breast milk is rich in lactoferrin, so breastfed infants can test positive without intestinal disease. NSAIDs and aspirin cause mucosal inflammation and raise the value. Barium and mineral oil interfere with the assay. Any cause of intestinal inflammation, including bacterial gastroenteritis and Clostridioides difficile colitis, raises it, so a positive result is not specific to inflammatory bowel disease. Urine or water contamination and prolonged room-temperature storage reduce reliability.
Explain that a single random stool specimen is enough and that fasting is not required. Confirm with the provider whether NSAIDs should be held. Schedule the test before any barium study and hold mineral oil. For an infant, note on the requisition whether the baby is breastfed so the laboratory and provider can interpret the result correctly.
The patient or caregiver collects a small portion of stool into the supplied container without adding water, urine, or toilet paper. Use gloves and standard precautions for handling, close the container securely, and label it at the point of collection.
Refrigerate and transport the specimen promptly. Restart any held medication. No recovery or monitoring is needed beyond continued assessment of the patient's stool pattern, hydration, and abdominal symptoms.
A positive result indicates neutrophils are entering the bowel lumen, which points to an inflammatory or invasive process: inflammatory bowel disease in relapse, invasive bacterial infection such as Shigella, Salmonella, or Campylobacter, C. difficile colitis, or pouchitis. A negative result argues for a noninflammatory cause such as a viral illness, a toxin-mediated infection, a malabsorptive process, or irritable bowel syndrome.
A positive result means inflammation is present, not which disease caused it, so always pair it with the infection workup before attributing it to inflammatory bowel disease.
Normal intestinal flora only, with no enteric pathogens isolated. Reports usually read as no growth of pathogenic organisms.
It is ordered to identify the organism causing infectious diarrhea, particularly when diarrhea is bloody, febrile, severe, prolonged beyond a few days, occurring after travel or antibiotic use, or part of a suspected outbreak. Identifying the pathogen guides whether an antibiotic is indicated, which one, and what public health reporting or isolation is required.
A stool specimen is placed on selective culture media that suppress normal flora and let enteric pathogens grow, and organisms that do grow are identified and tested against antibiotics. Many laboratories now run a molecular panel that detects the nucleic acid of a whole set of bacteria, viruses, and parasites at once, and reserve culture for organisms that need a live isolate for susceptibility testing or outbreak typing.
Antibiotics given before collection suppress organism growth and are the most common cause of a falsely negative culture. Barium, mineral oil, bismuth-containing preparations, magnesium-containing antacids, and antidiarrheal medications interfere with recovery of organisms. Urine, water from the toilet bowl, disinfectant residue in the container, and toilet paper all contaminate or kill the specimen. Letting a specimen sit at room temperature without transport medium allows normal flora to overgrow the pathogen.
Collect the specimen before antibiotics are started whenever the clinical situation allows. Explain that the sample must not be mixed with urine or toilet water, so the patient should void first and use a collection hat or clean bedpan. Ask about recent travel, antibiotic exposure, raw or undercooked food, well water, day care contact, and sick contacts, and record it, because that history tells the laboratory which pathogens to hunt for.
Have the patient pass stool into the clean container or hat, then transfer a portion, choosing any bloody, mucoid, or watery part, into the specimen container or transport medium and fill to the indicated line. Wear gloves and follow standard precautions, and place the patient on contact precautions if infectious diarrhea is suspected. When ova and parasite testing is added, expect a series of specimens collected on separate days rather than a single sample.
Send the specimen to the laboratory promptly, within about an hour if no transport medium is used, or refrigerate per your laboratory's policy. Document the time of collection and the specimen appearance. Continue to monitor hydration, electrolytes, stool frequency, and fever, and maintain isolation until results and policy allow it to be discontinued.
A positive culture identifies the causative organism, such as Salmonella, Shigella, Campylobacter, Yersinia, Vibrio, or Shiga toxin-producing Escherichia coli including O157:H7, and the susceptibility panel guides therapy. Shiga toxin-producing E. coli is a special case because antibiotics may increase the risk of hemolytic uremic syndrome. Clostridioides difficile is usually detected by toxin or molecular testing rather than routine culture. A negative culture in persistent diarrhea shifts attention to viruses, parasites, medications, inflammatory bowel disease, or malabsorption.
Collect the specimen before the first dose of antibiotic and get it to the laboratory fast, because both delay and prior antibiotics erase the organism you are trying to find.
No leukocytes seen on the smear.
It is a rapid, inexpensive screen that sorts acute diarrhea into inflammatory and noninflammatory categories while a culture is still pending. Finding white cells raises the likelihood of an invasive bacterial process and supports sending a culture and considering treatment, while their absence points toward a viral, toxin-mediated, or noninfectious cause.
When bacteria invade the intestinal wall, neutrophils migrate into the lumen and are shed with the stool. A thin smear of fresh stool, ideally taken from a mucoid or bloody portion, is stained with methylene blue or Wright stain and examined microscopically for white cells. Many laboratories have replaced this smear with fecal lactoferrin or calprotectin, which detect the same neutrophil traffic through more stable proteins.
White blood cells break down quickly, so a specimen that sits before it is smeared gives a falsely negative result. Barium, mineral oil, oily laxatives, and antidiarrheal agents interfere. A sample taken from a formed portion rather than from mucus or blood can miss the cells. Urine and toilet water contamination degrade the specimen, and the smear can also be positive in noninfectious inflammation such as ulcerative colitis, so it is not specific for infection.
Explain that only a small fresh sample is needed and that no fasting or diet change is required. Hold antidiarrheal medications and avoid scheduling after a barium study. Instruct the patient to void first and to collect into a clean container or hat, never from the toilet bowl.
Collect a fresh specimen and deliberately sample any portion containing blood, mucus, or pus. Use gloves and standard precautions, and place the patient on contact precautions if infectious diarrhea is suspected. Send the specimen immediately rather than holding it for the next scheduled pickup.
Document the time of collection and the stool appearance. Continue monitoring fluid and electrolyte status, stool frequency, and fever, and follow up on the culture or molecular panel, which is what actually names the organism.
The presence of leukocytes suggests an invasive or inflammatory process such as Shigella, Salmonella, Campylobacter, Yersinia, invasive Escherichia coli, or Clostridioides difficile colitis, and it also occurs in ulcerative colitis and Crohn disease. Their absence suggests a noninflammatory cause such as viral gastroenteritis, a toxin-producing organism such as enterotoxigenic E. coli or Vibrio cholerae, giardiasis, or a medication effect.
Smear a fresh specimen taken from the bloody or mucoid portion, because white cells lyse within hours and a delayed sample reads falsely negative.